Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Stock Report

| More

Alkem Contributes INR 7 Crores Towards Prime Minister's Citizen Assistance And Relief In Emergency Situations (PM CARES) Fund

Posted On: 2020-03-30 12:39:58

- Shri. Basudeo N. Singh - Executive Chairman, Alkem Laboratories Ltd. on behalf of over 18,000 Alkemites

- Alkem salutes the efforts of the entire medical fraternity and Central & State Governments to contain the spread of COVID-19

- Alkem contributes INR 7 Crores towards Prime Minister's Citizen Assistance and Relief in Emergency Situations (PM CARES) Fund

- Alkem ensuring uninterrupted supply of medicines and critical drugs in themarket to help the patients comply with their treatment

We are witnessing unprecedented times with pandemic COVID-19 casting its shadow not onlyin India but across more than 100 nations. Currently close to 7 lakhs people across the globe have tested positive for this virus and more than 33,000 people have lost their lives fighting it, and these number continue to rise by the day. However, it is heartening to see that the whole world stands united in this torrid times to beat this virus and emerge stronger and healthier than before. Every citizen is contributing to this fight by following the protocols set by the Central and State Governments and ensuring the safety of himself and the people around him at large.

In this respect, we would like to make a special mention about the efforts of the entire medical and support fraternity including doctors, paramedics, nurses, hospital staffs and healthcare workers who are providing an untiring and selfless service around the clock to help the affected patients. We salute them. We would also like to thank the Central and various State Governments for taking proactive measures to control the spread of this virus.

Alkem, as one of the leading pharmaceutical companies in the country, is committed in the above fight against this virus and is doing its bit to help the country and the world overcome these testing times. Our team of over 18,000 dedicated and passionate Alkemites across various departments like Manufacturing, Quality, Supply Chain, Research, IT, Finance and HR are working around the clock to ensure uninterrupted production and supply of medicines and critical drugs in the market to help our patients comply with their treatment. Additionally we are also making a contribution of INR 7 Crores towards Prime Minister's Citizen Assistance and Relief in Emergency Situations (PM CARES) Fund to help the Government in their initiatives in combating this virus.

We would also like to urge people across India and the world to continue in their efforts to contain the spread of this virus by adhering to social distancing norms, maintaining personal hygiene and taking caring of themselves and the people around them by staying at home and avoiding unnecessary travel.

Together we will and we would win over this virus and make world a healthier place.

Shares of Alkem Laboratories Ltd was last trading in BSE at Rs.2392.85 as compared to the previous close of Rs. 2309.1. The total number of shares traded during the day was 1937 in over 668 trades.

The stock hit an intraday high of Rs. 2452 and intraday low of 2233.85. The net turnover during the day was Rs. 4546133.

Source: Equity Bulls

Click here to send ur comments or to

Other Headlines:

RPG Life Sciences Ltd Q4 net profit at Rs. 2.98 crore

Kirloskar Brothers Ltd Q4 consolidated net profit at Rs. 23 crore

Silver Lake and Co-Investors to invest additional Rs. 4,546.80 crore in Jio Platforms

Saurashtra Cement Ltd takes annual maintenance shutdown at Ranavav factory

TIMKEN India Ltd board recommends dividend of Rs. 50

RPG Life Sciences Q4'FY 20 revenue up by 29%

Infibeam Avenues announces Fourth Quarter and Fiscal Year 2020 Results

L&T reports consolidated earnings for Q4, FY2020

Refex Industries Limited board to finalize rights issue terms

Greaves accelerates performance in new business initiatives with 21% contribution in FY20

TIMKEN India Ltd Q4 PAT at Rs. 61.26 crore

Natural Capsules Ltd posts Rs. 0.11 crore in Q4 FY20

SMS Pharmaceuticals Ltd Q4 PAT drops to Rs. 6.32 crore

Sumitomo Chemical India Ltd Q4 consolidated PAT at Rs. 22.90 crore

L&T Board recommends Final Dividend of Rs. 8

Natural Capsules Ltd Board approves dividend of Rs. 0.60

Jyothy Labs Ltd Q4 FY20 consolidated PAT at Rs. 28.80 crore

Aditya Birla Capital Ltd reports consolidated Q4 PAT of Rs. 143.67 crore

PPAP Automotive Ltd reports consolidated PAT of Rs. 5.85 crore in Q4 FY20

CG-VAK Software & Exports Ltd Q4 consolidated PAT at Rs. 1.28 crore

Exide Industries Ltd reports lower top line in Q4 FY2020

Gateway Distriparks Ltd announces FY2020 performance

CG-VAK Software and Exports Ltd board recommends dividend of Rs. 0.75 for FY20

Infibeam Avenues Ltd to acquire Cardpay Technologies Pvt Ltd

Pfizer Ltd Board to consider FY20 results & Final Dividend on June 15, 2020

Sumitomo Chemical India Ltd board declares dividend of Rs. 0.55

IRB InvIT Fund board declares 4th distribution of Rs. 1.80 for FY2020

Apollo Pipes Ltd launches water storage tank

Gujarat Gas Ltd Q4 consolidated PAT at Rs. 250.46 crore

Dr. Kiran Mazumdar-Shaw from India named EY World Entrepreneur Of The Year™ 2020

Alkem Laboratories Ltd Board approves final dividend of Rs. 3

SBI - Q4 / FY2020 Highlights

Mahindra to plant a tree for every service availed digitally on its With You Hamesha app

V-Guard presents new range of AIKIDO air coolers to beat the heat

IndiGo operates flight chartered by NALSAR to transport 174 migrant workers

Maruti Suzuki sells over 1 lakh factory fitted CNG vehicles - Highest ever in a fiscal

Alkem Laboratories Ltd Q4FY20 consolidated PAT at Rs. 188.77 crore

Lasa Supergenerics Ltd Q4 FY2020 PAT at Rs. 2.58 crore

Saregama India Ltd Board recommends dividend of Rs. 1.50

SBI Q4 FY20 consolidated PAT at Rs. 6909.95 crore

Suven Life Sciences Ltd reports loss of Rs. 25.55 crore in Q4 FY20

Saregama India Ltd Q4 consolidated PAT at Rs. 15.81 crore

Snowman reports optimistic results in pessimistic market outlook backed by Strong Fundamentals and Robust Business Model

Zydus Cadila receives final approval from USFDA for Atazanavir Capsules

Cheviot Company Ltd Q4 PAT falls to Rs. 3.50 crore

JSW Steel Ltd allots 10,000 NCDs

Sun Pharma initiates Phase II clinical trial on AQCH, a phytopharmaceutical drug, as potential treatment for COVID-19 patients

Maruti Suzuki commissions 5 MW carport style photovoltaic solar power plant in Gurugram

Hexaware Technologies Ltd board to consider voluntary delisting on June 12, 2020, stock locked in upper circuit

TCS Wins 2020 SAP® Pinnacle Award

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019